Ixekizumab cost effective versus secukinumab for plaque psoriasis
This is a preview of subscription content, log in to check access.
Johannson E, et al. Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain. ClinicoEconomics and Outcomes Research 2018: 747-759, No. 10, 12 Nov 2018. Available from: URL: https://doi.org/10.2147/CEOR.S167727CrossRefGoogle Scholar